by Josh Forsythe, on March 24, 2015
ST LOUIS, MO – PierianDx announced today that its genomic testing platform will soon produce a PDx Score giving clinicians prioritized, actionable and deeply informed data for a quicker diagnosis. PierianDx also announced the addition of clinical trials, FDA drug labels, and treatment guidelines from the National Comprehensive Cancer Network and the American Society of Clinical Oncology to its industry-leading knowledgebase.
Read StoryCheck back regularly for engaging perspectives on clinical genomics.
Global phone number: (314) 628-0035
U.S. Office: 6 Cityplace Dr Suite 550, Creve Coeur, MO 63141
India Office: 2/A, Chattushringi, Gokhalenagar, Pune, Maharashtra 411016, India